Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Kebebew Website

Electron Kebebew, M.D., F.A.C.S

Selected Publications

1)  Weisbrod AB, Webb RC, Mathur A, Barak S, Abraham SB, Nilubol N, Quezado M, Stratakis CA, Kebebew E.
Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.
Ann. Surg. Oncol. 20: 753-8, 2013.
2)  Weisbrod AB, Zhang L, Jain M, Barak S, Quezado MM, Kebebew E.
Altered PTEN, ATRX, CHGA, CHGB, and TP53 Expression Are Associated with Aggressive VHL-Associated Pancreatic Neuroendocrine Tumors.
Horm Cancer. [Epub ahead of print], 2013.
3)  Weisbrod AB, Nilubol N, Weinstein LS, Simonds WF, Libutti SK, Jensen RT, Marx SJ, Kebebew E.
Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.
J. Clin. Endocrinol. Metab. 98: E109-14, 2013.
4)  Liu-Chittenden Y, Kebebew E.
CpG island methylator phenotype in adrenocortical carcinoma: fact or fiction?.
J. Clin. Endocrinol. Metab. 98: 48-50, 2013.
5)  Kim WG, Zhu X, Kim DW, Zhang L, Kebebew E, Cheng SY.
Reactivation of the silenced thyroid hormone receptor ß gene expression delays thyroid tumor progression.
Endocrinology. 154: 25-35, 2013.
6)  Rahbari R, Kitano M, Zhang L, Bommareddi S, Kebebew E.
RTN4IP1 Is Down-Regulated in Thyroid Cancer and Has Tumor-Suppressive Function.
J. Clin. Endocrinol. Metab. 98: E446-54, 2013.
7)  Boufraqech M, Fassassi C, Kebebew E.
TLR-10 polymorphism and papillary thyroid cancer: one more SNP to consider?.
Endocrine. 43: 10-1, 2013.
8)  Jain M, Zhang L, He M, Zhang Y, Shen M, Kebebew E.
TOP2A is overexpressed and a therapeutic target for adrenocortical carcinoma.
Endocr. Relat. Cancer. [Epub ahead of print], 2013.
9)  Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM.
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.
Thyroid. 22: 1104-39, 2012.
10)  Kebebew E.
Anaplastic thyroid cancer: rare, fatal, and neglected.
Surgery. 152: 1088-9, 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 4/11/2013.